Article Text

Download PDFPDF

FRI0709-HPR Levels of satisfaction with psoriatic arthritis (PSA) treatment and associated alignment between rheumatologists and their patients across latin america
Free
  1. F. Zazzetti1,
  2. E.R. Soriano2,
  3. D. Rocio Gil3,
  4. J. Maldonado cocco4,
  5. D. Vega Morales5,
  6. I. Alves Pereira6,
  7. G. Guerra7,
  8. W. Bautista Molano8,
  9. J.C. Cassola9,
  10. V. Azevedo10,
  11. L.M. Aldunate1,
  12. S. Lobosco11
  1. 1Medical Affairs, JANSSEN
  2. 2Rheumatology Section, Hospital Italiano Buenos Aires, buenos aires, Argentina
  3. 3Rheumatology, Hospital Universitario Mayor MEDERI, Bogota, Colombia
  4. 4Rheumatology, Buenos Aires University School of Medicine, Buenos Aires, Argentina
  5. 5Rheumatology, Hospital Universitario "Dr. José Eleuterio González", Monterrey, Mexico
  6. 6Rheumatology, Universidade Federal de Santa Catarina, Hospital Universitário, Florianopolis, Brazil
  7. 7Rheumatology Section, Centro Médico Paitilla, panama, Panama
  8. 8Rheumatology, Universidad Militar Nueva Granada and Rheumatology Department, Hospital Militar, Bogota, Colombia
  9. 9Rheumatology Section, Hospital General de México, ciudad de Mexico, Mexico, Mexico
  10. 10Rheumatology, University of Paraná; Brazil, Parana, Brazil
  11. 11Rheumatology, Adelphi Group, Manchester, UK

Abstract

Objectives: To assess levels of rheumatologist and patient satisfaction with PsA treatment across Latin America and any disconnects that may exist between the two in real world clinical practice.

Methods: Data from the 2015 PsA Disease Specific Programme (DSP), a cross-sectional, multi-national survey of patients and rheumatologists conducted in Argentina, Mexico, Colombia and Venezuela were analyzed. Rheumatologists (n=141) completed forms containing patient demographics, patient disease severity and treatment satisfaction. Patients self-reported their level of treatment satisfaction and disease severity.

Results: A total of 293 PsA patients from across Latin America were included in this analysis. Current mean age was 49.9 years and 48.1% were female. Proportions of rheumatologists and patients reporting satisfaction with treatment were both similarly high (84% and 92% respectively), however current disease severity reporting differed more markedly between rheumatologists and patients (mild 78%/moderate-severe 22% rheumatologists vs. 63% mild/37% moderate-severe patients; p=0.002). When assessed for alignment, 19% of all rheumatologists and patients disagreed on the level of treatment satisfaction; 13% of this was due to rheumatologists stating greater dissatisfaction than their patients, with the remaining 6% due to patients stating greater dissatisfaction than their rheumatologists (p=0.0543). For current disease severity, 32% of all rheumatologists and patients disagreed; 25% due to patients stating greater severity than their rheumatologists, with 7% due to rheumatologists stating greater severity than their patients (p<0.001). Of those patients for whom their rheumatologist was satisfied with treatment, 14% were classified as having moderate to severe PsA by that same physician.

Conclusions: Despite many rheumatologists and their patients in Latin America reporting high levels of satisfaction with treatment, PsA patients can remain moderate to severe and disconnected from their physician. There is a need to improve physician/patient engagement as a means to improving clinical control.

Disclosure of Interest: None declared

Statistics from Altmetric.com

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.